A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung ca...
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
About this item
Full title
Author / Creator
Hurkmans, Daan P. , Basak, Edwin A. , van Dijk, Tanja , Mercieca, Darlene , Schreurs, Marco W. J. , Wijkhuijs, Annemarie J. M. , Bins, Sander , Hoop, Esther Oomen-de , Debets, Reno , Joerger, Markus , Odink, Arlette , van der Veldt, Astrid A. M. , van der Leest, Cor H. , Aerts, Joachim G. J. V. , Mathijssen, Ron H. J. and Koolen, Stijn L. W.
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Nivolumab is administered in a weight-based or fixed-flat dosing regimen. For patients with non-small cell lung cancer (NSCLC), a potential exposure-response relationship has recently been reported and may argue against the current dosing strategies. The primary objectives were to determine nivolumab pharmacokinetics (PK) and to assess the relation...
Alternative Titles
Full title
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
Authors, Artists and Contributors
Author / Creator
Basak, Edwin A.
van Dijk, Tanja
Mercieca, Darlene
Schreurs, Marco W. J.
Wijkhuijs, Annemarie J. M.
Bins, Sander
Hoop, Esther Oomen-de
Debets, Reno
Joerger, Markus
Odink, Arlette
van der Veldt, Astrid A. M.
van der Leest, Cor H.
Aerts, Joachim G. J. V.
Mathijssen, Ron H. J.
Koolen, Stijn L. W.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f8d983aed7774b85a3a382836c2bce1a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f8d983aed7774b85a3a382836c2bce1a
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1186/s40425-019-0669-y
